Child Developmental Delay
3
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Casita
Research Leaders
12 sponsors active, led by Canadian Institutes of Health Research (CIHR)
Related Conditions
Often studied with 12 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
BRIGHT Coaching Program for Families
Maternal B12 Supplementation to Improve Infant B12 Deficiency and Neurodevelopment
CASITA Intervention for Children at Risk of Delay in Carabayllo, Peru
Research Network
Common Treatments
- Casita1
- Online Parent Education1
- B12 Supplement1
- Coaching1
- Online Peer Support1
Active Sponsors
- Canadian Institutes of Health Research (CIHR)1
- Grand Challenges Canada1
- Boston Medical Center1
- Boston Children's Hospital1
- Harvard University1
Top Investigators
Socios En Salud, Peru
University College, London
Research Institute of McGill University Health Centre
Provincial Health Services Authority British Columbia
Related Conditions
- Child Malnutrition1
- Child Development1
- Child Development Disorder1
- Community Health Workers1
- Maternal Exposure1